Mackenzie Mills
Biographic Data
| ID | 8519960 |
|---|---|
| NAME | Mackenzie Mills |
| GIVEN NAMES | Mackenzie |
| FAMILY NAME | Mills |
| SIGNATURE | MILLS M |
| AFFILIATIONS | Department of Health Policy and Medical Technology Research Group - LSE Health, The London School of Economics and Political Science, Cowdrey House, Houghton Street, London WC2A 2AE, UK |
| ORCID | 0000-0002-8756-3484 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
How do HTA agencies perceive conditional approval of medicines? Evidence from England, Scotland, France and Canada
There is a growing disconnect between regulatory agencies that are promoting expedited approval to medicines based on early phase clinical evidence and health technology assessment (HTA) agencies that require robust clinical evidence to inform coverage decisions. This paper provides an assessment of the evidence gap between regulatory and HTA agencies on medicines receiving conditional marketing authorisation (CMA) and examines how HTA agencies i…
Sin taxes and their effect on consumption, revenue generation and health improvement
Sin or public health taxes are excise taxes imposed on the consumption of potentially harmful goods for health [sugar-sweetened beverages (SSBs), tobacco, alcohol, among others], aiming to reduce consumption, raise additional revenue and/or improve population health. This paper assesses the extent to which sin taxes (a) can reduce consumption of potentially harmful goods, (b) raise revenue for national health systems and (c) contribute to populat…
Do pharmaceutical budgets deliver financial sustainability in healthcare? Evidence from Europe
Payers have increasingly implemented a variety cost-containment measures to promote sustainability in the pharmaceutical sector. This paper provides an assessment of a range of different applications of pharmaceutical budgets and assesses their impact in the context of health financing goals. A comprehensive literature review was carried out in order to identify evidence on the presence and impact of pharmaceutical budget-setting and capping mech…
No prominent works on this page.
Do pharmaceutical budgets deliver financial sustainability in healthcare? Evidence from Europe
Payers have increasingly implemented a variety cost-containment measures to promote sustainability in the pharmaceutical sector. This paper provides an assessment of a range of different applications of pharmaceutical budgets and assesses their impact in the context of health financing goals. A comprehensive literature review was carried out in order to identify evidence on the presence and impact of pharmaceutical budget-setting and capping mech…
Sin taxes and their effect on consumption, revenue generation and health improvement
Sin or public health taxes are excise taxes imposed on the consumption of potentially harmful goods for health [sugar-sweetened beverages (SSBs), tobacco, alcohol, among others], aiming to reduce consumption, raise additional revenue and/or improve population health. This paper assesses the extent to which sin taxes (a) can reduce consumption of potentially harmful goods, (b) raise revenue for national health systems and (c) contribute to populat…
How do HTA agencies perceive conditional approval of medicines? Evidence from England, Scotland, France and Canada
There is a growing disconnect between regulatory agencies that are promoting expedited approval to medicines based on early phase clinical evidence and health technology assessment (HTA) agencies that require robust clinical evidence to inform coverage decisions. This paper provides an assessment of the evidence gap between regulatory and HTA agencies on medicines receiving conditional marketing authorisation (CMA) and examines how HTA agencies i…
Alternative medicine (1 work) · Authorization (1 work) · Economics (1 work) · Evidence-based policy (1 work) · Geography (1 work) · Health care (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · Health technology (1 work) · Healthcare cost, quality, practices (1 work) · Humanities (1 work)